These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 14976064)

  • 1. CD38 on B-cell chronic lymphocytic leukemia cells has higher expression in lymph nodes than in peripheral blood or bone marrow.
    Jaksic O; Paro MM; Kardum Skelin I; Kusec R; Pejsa V; Jaksic B
    Blood; 2004 Mar; 103(5):1968-9. PubMed ID: 14976064
    [No Abstract]   [Full Text] [Related]  

  • 2. CD38 is a signaling molecule in B-cell chronic lymphocytic leukemia cells.
    Deaglio S; Capobianco A; Bergui L; Dürig J; Morabito F; Dührsen U; Malavasi F
    Blood; 2003 Sep; 102(6):2146-55. PubMed ID: 12763926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD38 expression in B-chronic lymphocytic leukemia: association with clinical presentation and outcome in 155 patients.
    Domingo-Domènech E; Domingo-Clarós A; Gonzàlez-Barca E; Beneitez D; Alonso E; Romagosa V; De Sanjos S; Petit J; Grañena A; Fernández de Sevilla A
    Haematologica; 2002 Oct; 87(10):1021-7. PubMed ID: 12368155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous expression of CD38 and its ligand CD31 by chronic lymphocytic leukemia B-cells: anecdotal observation or pathogenetic hypothesis for the clinical outcome?
    Morabito F; Mangiola M; Stelitano C; Deaglio S; Callea V; Malavasi F
    Haematologica; 2003 Mar; 88(3):354-5. PubMed ID: 12651280
    [No Abstract]   [Full Text] [Related]  

  • 5. C-kit receptor (CD117) expression on plasma cells in monoclonal gammopathies.
    Kraj M; Pogłód R; Kopeć-Szlezak J; Sokołowska U; Woźniak J; Kruk B
    Leuk Lymphoma; 2004 Nov; 45(11):2281-9. PubMed ID: 15512818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CLL B cells with a bimodal CD38 expression pattern: persistence of bimodal populations despite effective therapy for B-CLL.
    Pittner BT; Jelinek DF; Kay NE
    Leukemia; 2004 Jan; 18(1):180-2. PubMed ID: 14523466
    [No Abstract]   [Full Text] [Related]  

  • 7. The prognostic value of CD38 expression and its quantification in B cell chronic lymphocytic leukemia (B-CLL).
    Mainou-Fowler T; Dignum HM; Proctor SJ; Summerfield GP
    Leuk Lymphoma; 2004 Mar; 45(3):455-62. PubMed ID: 15160906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between cell surface expression of CD38 and of vascular endothelial growth factor in B-cell chronic lymphocytic leukemia.
    McCabe D; O'Regan K; Murphy PT
    Leuk Res; 2004 Nov; 28(11):1239-40. PubMed ID: 15380351
    [No Abstract]   [Full Text] [Related]  

  • 9. Conversion of CD38 and/or myeloid-associated marker expression status during the course of B-CLL: association with a change to an aggressive clinical course.
    Chang CC; Cleveland RP
    Blood; 2002 Aug; 100(3):1106. PubMed ID: 12150158
    [No Abstract]   [Full Text] [Related]  

  • 10. CD38 and CD100 lead a network of surface receptors relaying positive signals for B-CLL growth and survival.
    Deaglio S; Vaisitti T; Bergui L; Bonello L; Horenstein AL; Tamagnone L; Boumsell L; Malavasi F
    Blood; 2005 Apr; 105(8):3042-50. PubMed ID: 15613544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MUM1/IRF4 expression is an unfavorable prognostic factor in B-cell chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL).
    Ito M; Iida S; Inagaki H; Tsuboi K; Komatsu H; Yamaguchi M; Nakamura N; Suzuki R; Seto M; Nakamura S; Morishima Y; Ueda R
    Jpn J Cancer Res; 2002 Jun; 93(6):685-94. PubMed ID: 12079517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CXCR4 expression is associated with survival in familial chronic lymphocytic leukemia, but CD38 expression is not.
    Ishibe N; Albitar M; Jilani IB; Goldin LR; Marti GE; Caporaso NE
    Blood; 2002 Aug; 100(3):1100-1. PubMed ID: 12150154
    [No Abstract]   [Full Text] [Related]  

  • 13. Expression of the chemokine receptors CXCR4 and CCR7 and disease progression in B-cell chronic lymphocytic leukemia/ small lymphocytic lymphoma.
    Ghobrial IM; Bone ND; Stenson MJ; Novak A; Hedin KE; Kay NE; Ansell SM
    Mayo Clin Proc; 2004 Mar; 79(3):318-25. PubMed ID: 15008605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relative importance of CD38 expression over myeloid-associated markers expression in predicting the clinical course of B-CLL patients.
    Chang CC; Liu CZ; Cleveland RP
    Leuk Lymphoma; 2003 Jun; 44(6):977-82. PubMed ID: 12854897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chromosomal aberrations and CD38 expression in two siblings with B-cell chronic lymphocytic leukemia: a report of two siblings.
    Méhes L; Balázs M; Rejtö L; Telek B; Kiss A; Udvardy M
    Leuk Lymphoma; 2005 Mar; 46(3):421-3. PubMed ID: 15621833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pattern of CD38 expression defines a distinct subset of chronic lymphocytic leukemia (CLL) patients at risk of disease progression.
    Ghia P; Guida G; Stella S; Gottardi D; Geuna M; Strola G; Scielzo C; Caligaris-Cappio F
    Blood; 2003 Feb; 101(4):1262-9. PubMed ID: 12406914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of CD38 expression and diagnostic immunophenotypic score in B cell chronic lymphocytic leukemia.
    Kartsios C; Yiannaki E; Eleftheriadis T; Katodritou E; Ditsa M; Zervas K; Markala D
    Acta Haematol; 2007; 118(2):126-8. PubMed ID: 17785962
    [No Abstract]   [Full Text] [Related]  

  • 18. CD38 modifications in chronic lymphocytic leukemia: are they relevant?
    Ghia P; Guida G; Scielzo C; Geuna M; Caligaris-Cappio F
    Leukemia; 2004 Oct; 18(10):1733-5. PubMed ID: 15343349
    [No Abstract]   [Full Text] [Related]  

  • 19. Retinoic acid induction of CD38 antigen expression on normal and leukemic human myeloid cells: relationship with cell differentiation.
    Prus E; Fibach E
    Leuk Lymphoma; 2003 Apr; 44(4):691-8. PubMed ID: 12769347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of CD38 in human promyelocytic leukemia HL-60 cell line during differentiation by niacin-related compounds.
    Iwata K; Ogata S; Okumura K; Taguchi H
    Biosci Biotechnol Biochem; 2003 Aug; 67(8):1836-9. PubMed ID: 12951526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.